866-997-4948(US-Canada Toll Free)

MAQUET Cardiovascular, LLC - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 37 Pages


MAQUET Cardiovascular, LLC is one of the leading company in providing innovative products for cardiac surgery, vascular intervention and cardiac support. Its key products include graft solutions, on and off pump solutions, thoracic abdominal and vascular therapies, cardiac perfusion products and extra corporeal life support systems. Its cardiopulmonary products include heart-lung machines, oxygenators, and disposables for open-heart surgery. The company also offers a new enhanced product line of on and off-pump cardiac surgery technologies and endoscopic vessel harvesting systems for cardiac surgery patients. The company offers its products to hospitals, clinics, the cardiac surgeons, interventional cardiologists and perfusionists. MAQUET Cardiovascular is a subsidiary of MAQUET GmbH & Co. KG and is headquartered in Wayne, New Jarsey, the US.

The company seeks to build its position in the marketplace through internal development, partnerships, strategic alliances and acquisition of complementary businesses, technologies and products. As part of its strategy, MAQUET Cardiovascular recently acquired Atrium Medical Corporation. The company also invest in the development of innovative technologies and solutions that advance clinical practice, improve patient outcomes and enhance quality of life.

This report is a source for data, analysis and actionable intelligence on the MAQUET Cardiovascular, LLC portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Key Facts 5
MAQUET Cardiovascular, LLC - Major Products and Services 6
MAQUET Cardiovascular, LLC Pipeline Products by Equipment Type 7
MAQUET Cardiovascular, LLC Pipeline Products by Development Stage 9
MAQUET Cardiovascular, LLC Pipeline Products by Therapy Area 11
MAQUET Cardiovascular, LLC Pipeline Products by Trial Phase 13
MAQUET Cardiovascular, LLC Pipeline Products by Milestone Summary 15
FUSION BIOLINE Vascular Graft 17
FUSION BIOLINE Vascular Graft Product Status 17
FUSION BIOLINE Vascular Graft Product Description 17
FUSION BIOLINE Vascular Graft Product Milestone 17
FUSION BIOLINE Vascular Graft Clinical Trial 18
Fusion Vascular Access Graft 20
Fusion Vascular Access Graft Product Status 20
Fusion Vascular Access Graft Product Description 20
Fusion Vascular Access Graft Product Milestone 20
Fusion Vascular Access Graft Clinical Trial 21
Integrated Magnus OR Table System 25
Integrated Magnus OR Table System Product Status 25
Integrated Magnus OR Table System Product Description 25
Integrated Magnus OR Table System Product Patent Details 25
MAQUET Cardiovascular, LLC - Key Competitors 31
MAQUET Cardiovascular, LLC - Key Employees 32
MAQUET Cardiovascular, LLC - Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
MAQUET Cardiovascular, LLC, Recent Developments 34
May 14, 2012: Maquet Cardiovascular Receives FDA 510(k) Clearance For New Mega Intra-Aortic Balloon Catheter Sizes 34
May 14, 2012: Maquet Cardiovascular Receives CE Mark For New Mega Intra-Aortic Balloon Catheter Sizes 34
Oct 17, 2011: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Intra-Aortic Balloon Catheters And Pumps 35
Oct 10, 2011: MAQUET Cardiovascular Signs Three-Year Contract With Premier For Intra-Aortic Balloon Pumps 35
May 06, 2011: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Open Heart Disposable Supplies 35
Apr 26, 2011: MAQUET Cardiovascular Launches QUADROX-i Neonatal And Pediatric Oxygenators And Reservoirs In US 35
Apr 22, 2011: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Vascular Grafts 36
Jan 31, 2011: Maquet Cardiovascular Launches Acrobat-i Stabilizer And Positioner System For Off-Pump CABG At Society Of Thoracic Surgery Meeting In San Diego 36

Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Table


MAQUET Cardiovascular, LLC, Key Facts 1
MAQUET Cardiovascular, LLC Key Pipeline Products by Equipment Type 1
MAQUET Cardiovascular, LLC Key Pipeline Products by Therapy Area 1
MAQUET Cardiovascular, LLC Key Pipeline Products by Development Stage 1
MAQUET Cardiovascular, LLC Key Pipeline Products by Trial Phase 1
MAQUET Cardiovascular, LLC, Key Facts 5
MAQUET Cardiovascular, LLC, Major Products and Services 6
MAQUET Cardiovascular, LLC Number of Pipeline Products by Equipment Type 7
MAQUET Cardiovascular, LLC Pipeline Products by Equipment Type 8
MAQUET Cardiovascular, LLC Number of Pipeline Products by Development Stage 9
MAQUET Cardiovascular, LLC Pipeline Products by Development Stage 10
MAQUET Cardiovascular, LLC Number of Pipeline Products by Therapy Area 11
MAQUET Cardiovascular, LLC Pipeline Products by Therapy Area 12
MAQUET Cardiovascular, LLC Number of Pipeline Products by Trial Phase 13
MAQUET Cardiovascular, LLC Pipeline Products by Trial Phase 14
MAQUET Cardiovascular, LLC Number of Pipeline Products By Milestone Summary 15
MAQUET Cardiovascular, LLC Pipeline Products by Milestone Summary 16
FUSION BIOLINE Vascular Graft - Product Status 17
FUSION BIOLINE Vascular Graft - Product Description 17
FUSION BIOLINE Vascular Graft - Product Milestone 17
FUSION BIOLINE Vascular Graft - First Patient Randomized Investigational Device Exemption Clinical Trial 18
Fusion Vascular Access Graft - Product Status 20
Fusion Vascular Access Graft - Product Description 20
Fusion Vascular Access Graft - Product Milestone 20
Fusion Vascular Access Graft - ACCESS: Prospective, Multi-Center Trial of the Fusion Vascular Access Graft for Patients Who Require Early Vascular Access for Hemodialysis 21
Fusion Vascular Access Graft - First Patient Randomized Investigational Device Exemption Clinical Trial 23
Fusion Vascular Access Graft - Study of PERipheral Bypass GraFting: ProspECTive Evaluation of FUSION Vascular Graft for Above Knee Targets(PERFECTION) 24
Integrated Magnus OR Table System - Product Status 25
Integrated Magnus OR Table System - Product Description 25
Integrated Magnus OR Table System - Patent Details1 25
Integrated Magnus OR Table System - Patent Details2 26
Integrated Magnus OR Table System - Patent Details3 26
Integrated Magnus OR Table System - Patent Details4 27
Integrated Magnus OR Table System - Patent Details5 28
Integrated Magnus OR Table System - Patent Details6 28
Integrated Magnus OR Table System - Patent Details7 29
Integrated Magnus OR Table System - Patent Details8 29
Integrated Magnus OR Table System - Patent Details9 30
MAQUET Cardiovascular, LLC, Key Employees 32

List of Chart


MAQUET Cardiovascular, LLC Key Pipeline Products by Equipment Type 1
MAQUET Cardiovascular, LLC Pipeline Products by Equipment Type 7
MAQUET Cardiovascular, LLC Pipeline Products by Development Stage 9
MAQUET Cardiovascular, LLC Pipeline Products by Therapy Area 11
MAQUET Cardiovascular, LLC Pipeline Products by Trial Phase 13
MAQUET Cardiovascular, LLC Pipeline Products by Milestone Summary 15

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *